- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
March 28, 2023Robins Kaplan LLP Announces 2023 Leadership Council on Legal Diversity (LCLD) Fellow and Pathfinder
March 22, 2023Benchmark Litigation Names Robins Kaplan 2023 Minnesota Law Firm of the Year
March 16, 2023Second Circuit Affirms Record $5.6 Billion Recovery in Antitrust Case
March 29-30, 2023ACI Managed Care Disputes and Litigation
April 3, 2023Conference of Tribal Lending Commissioners
April 11-13, 2023Mass Torts Made Perfect Seminar
March 2023Unintended Consequences of Banning Noncompete Agreements
March 26, 2023What I’ll Be Watching for in the Amgen Oral Arguments
March 13, 2023The Antitrust Case that Could Reshape Professional Golf
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Gene, Method Patent Rulings Said Top Issues for Life Sciences This Year
January 11, 2013
Reproduced with permission from Life Sciences Law & Industry Report, 7 LSLR 63 (Jan. 11, 2013). Copyright 2013 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
Read the full article (PDF) with quotes from Sharon Roberg-Perez.
For 2013, much of the focus in the life sciences industry will be on patents, experts in life sciences predicted for BNA. Patentable subject matter in the United States and Europe, the scope of the patent infringement ‘‘safe harbor’’ provision, and ‘‘patent exhaustion’’ will be the top issues for 2013 as a result of the impact of past and anticipated court rulings, they said.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.